triazolam and Gas Gangrene
triazolam has been researched along with Gas Gangrene in 1 studies
Triazolam: A short-acting benzodiazepine used in the treatment of insomnia. Some countries temporarily withdrew triazolam from the market because of concerns about adverse reactions, mostly psychological, associated with higher dose ranges. Its use at lower doses with appropriate care and labeling has been reaffirmed by the FDA and most other countries.
Gas Gangrene: A severe condition resulting from bacteria invading healthy muscle from adjacent traumatized muscle or soft tissue. The infection originates in a wound contaminated with bacteria of the genus CLOSTRIDIUM. C. perfringens accounts for the majority of cases (over eighty percent), while C. noyvi, C. septicum, and C. histolyticum cause most of the other cases.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Haiart, DC | 1 |
Andrade, B | 1 |
Murie, JA | 1 |
Other Studies
1 other study available for triazolam and Gas Gangrene
Article | Year |
---|---|
Gas gangrene following intra-arterial injection of oral medication in a drug abuser.
Topics: Accidents; Adult; Animals; Cyclizine; Femoral Artery; Gas Gangrene; Humans; Injections, Intra-Arteri | 1992 |